The impact on comorbidities in deciding the dose for the first cycle of chemotherapy

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter E. Una Cidon
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors E. Una Cidon
  • Oncology Department, Royal Bournemouth Hospital, NHS Foundation Trust, Bournemouth, United Kingdom, /

Abstract

The treatment of patients with cancer and comorbidities could be challenging as these patients are not represented in clinical trials. We carried out a study to evaluate the relevance of the comorbidities in deciding the first cycle dose of chemotherapy and the patients' tolerance and compliance.